Emergent BioSolutions Inc. (EBS)’s Stock Is Buy After Touching 52-Week High

Posted on


  1. Emergent BioSolutions Inc. (EBS)’s Stock Is Buy After Touching 52-Week High  BZ Weekly
  2. Emergent Biosolutions (NYSE:EBS) Rating Lowered to Hold at Zacks Investment Research  TrueBlueTribune
  3. Full coverage

Image Result For Emergent Biosolutions Inc Ebs

Image Result For Emergent Biosolutions Inc Ebs



Emergent BioSolutions provides specialty products for civilian and military populations that address intentional and naturally emerging public health threats..Emergent BioSolutions Inc. focuses on the development, manufacture, and commercialization of medical countermeasures that address public health threats. Its products address public health threats primarily chemical, biological, radiological, nuclear, and explosive related threats, as well as infectious diseases..Emergent Biosolutions Inc. stock price, stock quotes and financial overviews from MarketWatch..







Leave a Reply

Your email address will not be published. Required fields are marked *